Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dog
Open Access
- 14 November 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 31, 101159
Abstract
No abstract availableKeywords
Funding Information
- Institute for Translational Medicine and Therapeutics
- National Institutes of Health
- University of Pennsylvania (HL07439)
- Perelman School of Medicine, University of Pennsylvania
- National Heart, Lung, and Blood Institute (HL158781)
- National Heart, Lung, and Blood Institute (HL07439)
- National Heart, Lung, and Blood Institute (N01_7N92019D00041)
This publication has 44 references indexed in Scilit:
- Estimating abundances of retroviral insertion sites from DNA fragment length dataBioinformatics, 2012
- Efficacy and Safety of Long-term Prophylaxis in Severe Hemophilia A Dogs Following Liver Gene Therapy Using AAV VectorsMolecular Therapy, 2011
- Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyBlood, 2010
- Long-Term Efficacy of Adeno-Associated Virus Serotypes 8 and 9 in Hemophilia A Dogs and MiceHuman Gene Therapy, 2006
- Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman PrimatesMolecular Therapy, 2006
- Characterization of Adeno-Associated Virus Genomes Isolated from Human TissuesJournal of Virology, 2005
- Breed incidence of lymphoma in a UK population of insured dogsVeterinary and Comparative Oncology, 2003
- Characteristics of Hodgkin's Lymphoma after Infectious MononucleosisNew England Journal of Medicine, 2003
- Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in MuscleJournal of Virology, 2003
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001